We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Molecular Marker Predicts Patients Most Likely to Benefit Longest From Two Popular Cancer Drugs

News   Sep 11, 2013

 
Molecular Marker Predicts Patients Most Likely to Benefit Longest From Two Popular Cancer Drugs
 
 
 

RELATED ARTICLES

Atlas of Genetic Regulation of Lipid Metabolism Created

News

An international research team has identified several novel genetic variants associated with plasma levels of lipid species and cardiovascular disease risk in humans. The study demonstrates that genetic studies focusing on circulating molecular lipid levels over traditional lipid measures can help improve cardiovascular risk prediction and treatment.

READ MORE

Variability in High Cholesterol Risk Genes Calls for Greater Diversity in Genetics Research

News

Some of the genes that predict the risk of high cholesterol don't apply to people from Uganda the same as they do in European populations, finds a new UCL-led study.

READ MORE

Study Explores Integrity of Research Specimens

News

Biological samples can be highly susceptible to changes over time, and degraded samples can produce spurious results in research. To address these concerns, scientists have designed a highly sensitive test that can be used to establish the integrity of blood plasma and serum, the most common biosamples used in medical research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE